🔗 Permalink

Inventor profile of:

Fabio Bertozzi

City:

Genova

Country:

Italy

Published Applications:

Last publication date:

2024-05-02

Top Assignees for applications by Fabio Bertozzi

The entities that hold a legal rights for patent applications filed by inventor Bertozzi Fabio:

The Regents of the University of California 3 Oakland, CA United States
Universita Degli Studi Di Parma 3 Parma, Italy
Universita Degli Studi Di Urbino "Carlo Bo" 3 Urbino, Italy
Fondazione Istituto Italiano di Tecnologia 3 Genoa, Italy
Fondazione Istituto Italiano Di Technologia 2 Genoa, Italy
Fondazione Istituto Italiano di Tecnologia 1 , Italy
Istituto Giannina Gasiini 1 Genoa, Italy
FondaZione Per La Ricerca Sulla Fibrosi Cristica—Onlus 1 Verona, Italy
FONDAZIONE ISTITUTO ITALIANO DI TECHNOLOGIA 1 Genova, Italy

Recent patent applications by Bertozzi Fabio

Fabio Bertozzi from Genova, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-02

US20240140936A1

Chemistry; metallurgy

METHOD FOR THE PREPARATION OF PYRAZOLE DERIVATIVES AS MODULATORS OF CFTR PROTEIN

#2 | 2023-07-06

US20230212157A1

Chemistry; metallurgy

PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CYSTIC FIBROSIS

#3 | 2022-03-24

US20220089584A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

#4 | 2021-09-23

US20210292324A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

#5 | 2020-11-26

US20200369663A1

Chemistry; metallurgy

Compounds and compositions for the treatment of cystic fibrosis

#6 | 2020-04-30

US20200131157A1

Chemistry; metallurgy

Pyrazole derivatives for the treatment of cystic fibrosis

#7 | 2020-01-02

US20200002348A1

Chemistry; metallurgy

Heterocyclic derivatives for the treatment of cystic fibrosis

#8 | 2019-05-09

US20190135802A1

Chemistry; metallurgy

Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment

#9 | 2019-05-09

US20190135778A1

Chemistry; metallurgy

Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions

#10 | 2016-08-18

US20160235707A1

Human necessities

DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA)

#11 | 2016-03-10

US20160068483A1

Chemistry; metallurgy

Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors

#12 | 2016-03-10

US20160068482A1

Chemistry; metallurgy

Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors

#13 | 2013-10-24

US20130281490A1

Chemistry; metallurgy

Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

InventorID:

498830 ⎘